IL33 and gout: In our study, we found that St2-/- mice displayed significantly reduced oxidative stress, ROS production and pain hypersensitivity in gout condition, whereas exogenously injected IL-33 further promoted oxidative stress, ROS production and exacerbated pain hypersensitivity in gout condition via ST2 dependent mechanism.